Maryam Fouladi, MD

Maryam Fouladi, MD, MSc, FRCP, is a pediatric neuro-oncologist, co-executive director of the pediatric neuro-oncology program at Nationwide Children’s Hospital, and a Professor of Pediatrics at the Ohio State University College of Medicine. Dr. Fouladi is an internationally recognized expert in pediatric brain tumors, and is particularly renowned for her work in phase I clinical trials. She is the founding director of CONNECT, an international consortium focused on developing and testing novel therapies in early phase clinical trials.

Fouladi’s primary research interest focus on brain stem gliomas (DIPG) and is the founding Chair of The International Diffuse Intrinsic Pontine Glioma (DIPG)/diffuse midline glioma (DMG) Registry. She has authored or co-authored over 140 peer-reviewed publications in leading medical journals.

In addition to her roles at Nationwide Children’s and Ohio State Wexner Medical Center, Dr. Fouladi serves as the Chair of the Collaborative Network for Neuro-Oncology Clinical Trials and CNS Committee of the Children’s Oncology Group.

Prior to coming to Nationwide Children’s, Dr. Fouladi served as medical director of the Brain Tumor Center at Cincinnati Children’s Hospital and was also a full professor and the Marjory J. Johnson Endowed Chair in Brain Tumor Translational Research. She received her medical degree from the University of Toronto, and completed her pediatric residency and hematology/oncology fellowship at The Hospital for Sick Children in Toronto.  She completed her neuro-oncology fellowship training at St. Jude Children’s Research Hospital followed by additional training in the Molecular Pharmacology Department at St. Jude Children’s Hospital.